Abstract
Publisher's Note: There is a Blood Commentary on this article in this issue.
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Combined Modality Therapy
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Postoperative Care*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Transplantation, Homologous
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors